Previous studies have found that PD-L1, which is highly expressed in tumor cells, interacts with programmed cell death receptor 1 (PD-1) on lymphocytes to inhibit the proliferation and activation of lymphocytes. The gene discussed is CD274; the disease is neoplasm.